Literature DB >> 26547205

Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis.

Yu Liu1,2, Liang-Fu Jiang2, Rong-Peng Zhang2, Wen-Tong Zhang3,4,5.   

Abstract

BACKGROUND: This meta-analysis aimed to determine the role of human fatty acid binding protein 2 (FABP2) expression in the diagnosis of necrotizing enterocolitis (NEC) of newborns. DATA SOURCES: Eligible studies for further statistical analysis were identified from various databases including PubMed, Expert Medica Database, Web of Science, Cochrane Library, Google Scholar, China BioMedicine and China National Knowledge Infrastructure. Random effects model was used, and summary standardized mean difference (SMD) with its 95% confidence interval (CI) was calculated to assess the association of FABP2 expression and NEC.
RESULTS: Ten articles which included 572 infants (262 infants with NEC and 310 healthy controls) were included in the current meta-analysis. FABP2 showed a positive relationship with NEC of newborns (SMD=2.88, 95% CI=2.09-3.67, P<0.001). And FABP2 expression was higher in patients with advanced stage of NEC (stage III or stage II+III) than in those with early stage of NEC (stage I) (SMD=-0.48, 95% CI=-0.87 to -0.09, P=0.015). Ethnicity-stratified analysis yielded significantly different estimates with a high FABP2 expression in NEC in both Caucasians (SMD=3.16, 95% CI=1.90-4.43, P<0.001) and Asians (SMD=2.57, 95% CI=1.50-3.64, P<0.001). Sample-based subgroup analysis showed that FABP2 expression was positively correlated with neonatal NEC in both urinary- and blood-sample subgroups (all P<0.05).
CONCLUSION: The results prove that the high FABP2 expression is related to the damage to intestinal cells, which may be a possible early detection marker identifying neonatal NEC.

Entities:  

Keywords:  fatty acid binding protein 2; meta-analysis; necrotizing enterocolitis of newborn; protein expression

Mesh:

Substances:

Year:  2015        PMID: 26547205     DOI: 10.1007/s12519-015-0035-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  27 in total

Review 1.  A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis.

Authors:  Nicholas Evennett; Nic Alexander; Maxim Petrov; Agostino Pierro; Simon Eaton
Journal:  J Pediatr Surg       Date:  2009-11       Impact factor: 2.545

2.  Intestinal fatty acid-binding protein: a possible marker for gut maturation.

Authors:  Kostan W Reisinger; Marieke Elst; Joep P M Derikx; Peter G J Nikkels; Bart de Vries; Marlou P M Adriaanse; Reint K Jellema; Boris W W Kramer; Tim G A M Wolfs
Journal:  Pediatr Res       Date:  2014-06-23       Impact factor: 3.756

3.  Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.

Authors:  Katherine E Gregory; Abigail B Winston; Hidemi S Yamamoto; Hassan Y Dawood; Titilayo Fashemi; Raina N Fichorova; Linda J Van Marter
Journal:  J Pediatr       Date:  2014-03-15       Impact factor: 4.406

4.  Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis.

Authors:  Nicholas J Evennett; Nigel J Hall; Agostino Pierro; Simon Eaton
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

Review 5.  Necrotizing enterocolitis: a practical guide to its prevention and management.

Authors:  Pinaki Panigrahi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis.

Authors:  Cumhur Aydemir; Dilek Dilli; Serife Suna Oguz; Hulya Ozkan Ulu; Nurdan Uras; Omer Erdeve; Ugur Dilmen
Journal:  Early Hum Dev       Date:  2011-06-08       Impact factor: 2.079

Review 7.  New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond.

Authors:  Amin Afrazi; Chhinder P Sodhi; Ward Richardson; Matthew Neal; Misty Good; Richard Siggers; David J Hackam
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

8.  Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants.

Authors:  Eddy W Y Ng; Terence C W Poon; Hugh S Lam; Hon M Cheung; Terence P Y Ma; Kathy Y Y Chan; Raymond P O Wong; Kam T Leung; Melody M T Lam; Karen Li; Pak C Ng
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

9.  Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters.

Authors:  Andrew Rowland; Kathleen M Knights; Peter I Mackenzie; John O Miners
Journal:  Drug Metab Dispos       Date:  2009-04-27       Impact factor: 3.922

10.  Intestinal flora in very low-birth weight infants.

Authors:  Markus V Björkström; Lina Hall; Stina Söderlund; Eva Grahn Håkansson; Stellan Håkansson; Magnus Domellöf
Journal:  Acta Paediatr       Date:  2009-08-08       Impact factor: 2.299

View more
  2 in total

Review 1.  The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.

Authors:  Shaun S C Ho; Jacqueline I Keenan; Andrew S Day
Journal:  Dig Dis Sci       Date:  2019-09-16       Impact factor: 3.199

2.  Potential Role of Serum Intestinal Fatty Acid-Binding Protein as a Marker for Early Prediction and Diagnosis of Necrotizing Enterocolitis in Preterm Neonates.

Authors:  Amin I E Shaaban; Osama A E Alfqy; Howayda M K Shaaban; Yahya H A-Maqsoud; Effat H Assar
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.